Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report
A 71-year-old female patient with B-cell depletion due to treatment with an anti-CD20 monoclonal antibody was admitted for worsening COVID-19. Overall, she had persistent viral shedding, worsening respiratory failure, and progressive pneumonia that did not improve despite dexamethasone and antibioti...
Guardado en:
Autores principales: | Ayham Daher, Tobias Müller, Jens Spiesshoefer, Michael Dreher, Jens Panse |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a834fbe74cfc422ea3aa8142f10c845b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Histiocitosis Hemofagocítica y Aplasia Medular en Fiebre Tifoidea
por: Valdés L,Verónica, et al.
Publicado: (1983) -
Aplasia medular después de un tratamiento con cloromicetina: Relato de un caso de evolución fatal
por: GARCES,HUMBERTO, et al.
Publicado: (1952) -
Aplasia cutis congénita: a propósito de cuatro casos: a study of 4 cases
por: Pérez C.,Lilian, et al.
Publicado: (2001) -
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab T, et al.
Publicado: (2021)